1352874-12-4Relevant articles and documents
KV3 ENHANCERS FOR THE TREATMENT OF COGNITIVE DISORDERS
-
Paragraph 0187, (2021/11/04)
The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L, Y1 to Y4 and R1 to R6 are as described herein.
BIPHENYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES
-
Page/Page column 49, (2012/01/06)
The invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of one or more IGF-1R mediated disorders or diseases